Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.40 |
| ▸ | HTR3B | O95264 | 1/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.40 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415600 | 1.00 | MAPT (0.56) | MAPTMEN1POLBKMT2AMCL1 | |
| Hydrochloric Acid SCHEMBL591717 | 0.97 | MAPT (0.54) | MAPTMEN1POLBKMT2AMCL1 | |
| Hydrochloric Acid SCHEMBL29483368 | 0.97 | MAPT (0.54) | MAPTMEN1POLBKMT2AMCL1 | |
| Hydrochloric Acid SCHEMBL30387908 | 0.97 | MAPT (0.54) | MAPTMEN1POLBKMT2AMCL1 | |
| Water SCHEMBL28525395 | 0.97 | MAPT (0.54) | MAPTMEN1POLBKMT2AMCL1 | |
| SCHEMBL15893452 | 0.84 | GAA (0.52) | MAPTMEN1POLBKMT2AMCL1 | |
| SCHEMBL1743405 | 0.82 | MAPT (0.47) | MAPTMEN1POLBKMT2AMCL1 | |
| SCHEMBL3073324 | 0.82 | MEN1 (0.47) | MAPTMEN1POLBKMT2AMCL1 | |
| SCHEMBL789208 | 0.82 | MAPT (0.47) | MAPTMEN1POLBKMT2AMCL1 | |
| SCHEMBL31146877 | 0.82 | MAPT (0.47) | MAPTMEN1POLBKMT2AMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264177-A1 | METHOD FOR CLEAVING PROTECTING GROUPS AND ORGANIC COMPOUNDS FROM SUPPORTS | POLYPEPTIDE LABORATORIES HOLDING (PPL) AB (SE) | 2025-12-26 | — | — | WO | claimed |
| US-20250290918-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2025-09-18 | — | — | US | claimed |
| US-12360119-B2 | Methods related to biologics | MOMENTA PHARMACEUTICALS, INC. (US) | 2025-07-15 | — | — | US | claimed |
| EP-4310503-A2 | METHODS RELATED TO BIOLOGICS | Momenta Pharmaceuticals, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| US-11796534-B2 | Methods for assessing cell surface glycosylation | JUNO THERAPEUTICS, INC. (US) | 2023-10-24 | — | — | US | claimed |
| US-20230324406-A1 | METHODS RELATED TO BIOLOGICS | MOMENTA PHARMACEUTICALS, INC. | 2023-10-12 | — | — | US | claimed |
| US-11719704-B2 | Methods related to biologics | MOMENTA PHARMACEUTICALS, INC. (US) | 2023-08-08 | — | — | US | claimed |
| EP-3983781-A1 | METHODS AND KITS TO IMPROVE THE FLUORESCENT SIGNAL OF DMB-LABELED SIALIC ACIDS | Agilent Technologies, Inc. (US) | 2022-04-20 | — | — | EP | claimed |
| CN-114041049-A | Method and kit for improving fluorescent signal of DMB-labeled sialic acid | 安捷伦科技有限公司 | 2022-02-11 | — | — | CN | claimed |
| US-20210255173-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2021-08-19 | — | — | US | claimed |
| WO-2020251862-A1 | METHODS AND KITS TO IMPROVE THE FLUORESCENT SIGNAL OF DMB-LABELED SIALIC ACIDS | AGILENT TECHNOLOGIES, INC. (US) | 2020-12-17 | — | — | WO | claimed |
| EP-3610261-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | Juno Therapeutics, Inc. (US) | 2020-02-19 | — | — | EP | claimed |
| CN-110709700-A | Method for evaluating cell surface glycosylation | 朱诺治疗学股份有限公司 | 2020-01-17 | — | — | CN | claimed |
| CN-109557207-A | Method for quantitatively determining substrate conversion and product generation and distribution in ALS/AHAS enzyme catalytic reaction process | 西北大学 | 2019-04-02 | — | — | CN | claimed |
| WO-2018191723-A1 | METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATION | JUNO THERAPEUTICS, INC. (US) | 2018-10-18 | — | — | WO | claimed |
| CN-108226333-A | Glucose degradation products detects and controls method in a kind of Multiple electrolytes injection | 青岛力腾化工医药研究有限公司 | 2018-06-29 | — | — | CN | claimed |
| US-20120264927-A1 | METHODS FOR LABELING GLYCANS | MOMENTA PHARMACEUTICALS, INC. | 2012-10-18 | — | — | US | claimed |
| US-20050214894-A1 | High throughput assay | ISIS INNOVATION LIMITED (GB) | 2005-09-29 | — | — | US | claimed |
| EP-4737508-A1 | CHEMICAL RECYCLING METHOD FOR MIXED WASTE POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2026-05-06 | — | — | EP | disclosed |
| EP-0449295-A1 | Novel quinoxalinone derivative | BIOSENSOR LABORATORIES CO., LTD. (JP) | 1991-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264927-A1 | METHODS FOR LABELING GLYCANS | FUT5, FUT6, ENGASE | MAPT 2507/4885MEN1 4499/4885POLB 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.